5043 related articles for article (PubMed ID: 22866313)
1. Changes in the levels of N-cadherin and PCNA in skin melanoma cells are mediated through matrix metalloproteinase 9.
Aksenenko MB; Gyrylova SN; Ruksha TG
Bull Exp Biol Med; 2012 Jul; 153(3):364-6. PubMed ID: 22866313
[TBL] [Abstract][Full Text] [Related]
2. MMP-9 overexpression is associated with intragenic hypermethylation of MMP9 gene in melanoma.
Falzone L; Salemi R; Travali S; Scalisi A; McCubrey JA; Candido S; Libra M
Aging (Albany NY); 2016 May; 8(5):933-44. PubMed ID: 27115178
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the application of MMP-9 inhibitor in skin melanoma: experimental study.
Aksenenko MB; Ruksha TG
Bull Exp Biol Med; 2013 Mar; 154(5):594-6. PubMed ID: 23658876
[TBL] [Abstract][Full Text] [Related]
4. Rictor regulates the vasculogenic mimicry of melanoma via the AKT-MMP-2/9 pathway.
Liang X; Sun R; Zhao X; Zhang Y; Gu Q; Dong X; Zhang D; Sun J; Sun B
J Cell Mol Med; 2017 Dec; 21(12):3579-3591. PubMed ID: 28699701
[TBL] [Abstract][Full Text] [Related]
5. Influence of the cytoplasmic domain of E-cadherin on endogenous N-cadherin expression in malignant melanoma.
Kuphal S; Bosserhoff AK
Oncogene; 2006 Jan; 25(2):248-59. PubMed ID: 16132038
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of Hsp27 in a human melanoma cell line: regulation of E-cadherin, MUC18/MCAM, and plasminogen activator (PA) system.
Aldrian S; Kindas-Mügge I; Trautinger F; Fröhlich I; Gsur A; Herbacek I; Berger W; Micksche M
Cell Stress Chaperones; 2003; 8(3):249-57. PubMed ID: 14984058
[TBL] [Abstract][Full Text] [Related]
7. RNAi-mediated human Nestin silence inhibits proliferation and migration of malignant melanoma cells by G
Yang XH; Xia T; Zhang J; Yang SF; Tang HX; Tang T; Huang ZC; Zhong YS; He F; Xiang AP
J Huazhong Univ Sci Technolog Med Sci; 2017 Dec; 37(6):895-903. PubMed ID: 29270750
[TBL] [Abstract][Full Text] [Related]
8. The inhibition of invasion of human melanoma cells through N-cadherin knock-down.
Ciołczyk-Wierzbicka D; Laidler P
Med Oncol; 2018 Feb; 35(4):42. PubMed ID: 29492694
[TBL] [Abstract][Full Text] [Related]
9. [Expression and significance of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase in non-melanoma skin cancer].
Fu XR; Zhang C; Chen CY; Zhang L; Wang LX; Wang BH; Liu XY; Zhang MZ
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):369-73. PubMed ID: 22883459
[TBL] [Abstract][Full Text] [Related]
10. Interplay between cadherins and α2β1 integrin differentially regulates melanoma cell invasion.
Siret C; Terciolo C; Dobric A; Habib MC; Germain S; Bonnier R; Lombardo D; Rigot V; André F
Br J Cancer; 2015 Nov; 113(10):1445-53. PubMed ID: 26512877
[TBL] [Abstract][Full Text] [Related]
11. E-cadherin suppression accelerates squamous cell carcinoma progression in three-dimensional, human tissue constructs.
Margulis A; Zhang W; Alt-Holland A; Crawford HC; Fusenig NE; Garlick JA
Cancer Res; 2005 Mar; 65(5):1783-91. PubMed ID: 15753375
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical expression of vascular endothelial growth factor, matrix metalloproteinase 2, and matrix metalloproteinase 9 in cutaneous melanocytic lesions.
Simonetti O; Lucarini G; Brancorsini D; Nita P; Bernardini ML; Biagini G; Offidani A
Cancer; 2002 Nov; 95(9):1963-70. PubMed ID: 12404291
[TBL] [Abstract][Full Text] [Related]
13. DDR2 inhibition reduces migration and invasion of murine metastatic melanoma cells by suppressing MMP2/9 expression through ERK/NF-κB pathway.
Poudel B; Lee YM; Kim DK
Acta Biochim Biophys Sin (Shanghai); 2015 Apr; 47(4):292-8. PubMed ID: 25733533
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-6-induced Twist and N-cadherin enhance melanoma cell metastasis.
Na YR; Lee JS; Lee SJ; Seok SH
Melanoma Res; 2013 Dec; 23(6):434-43. PubMed ID: 24051540
[TBL] [Abstract][Full Text] [Related]
15. Cadherin switch from E- to N-cadherin in melanoma progression is regulated by the PI3K/PTEN pathway through Twist and Snail.
Hao L; Ha JR; Kuzel P; Garcia E; Persad S
Br J Dermatol; 2012 Jun; 166(6):1184-97. PubMed ID: 22332917
[TBL] [Abstract][Full Text] [Related]
16. miR-128 targets the CC chemokine ligand 18 gene (CCL18) in cutaneous malignant melanoma progression.
Song H; Tao Y; Ni N; Zhou X; Xiong J; Zeng X; Xu X; Qi J; Sun J
J Dermatol Sci; 2018 Sep; 91(3):317-324. PubMed ID: 30025750
[TBL] [Abstract][Full Text] [Related]
17. Adhesion, migration and communication in melanocytes and melanoma.
Haass NK; Smalley KS; Li L; Herlyn M
Pigment Cell Res; 2005 Jun; 18(3):150-9. PubMed ID: 15892711
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of BRCA1 in A375 melanoma cell line increases radio-sensitivity and modifies metastatic and angiogenic gene expression.
Hesling C; D'Incan M; D'Incan C; Souteyrand P; Monboisse JC; Pasco S; Madelmont JC; Bignon YJ
J Invest Dermatol; 2004 Feb; 122(2):369-80. PubMed ID: 15009718
[TBL] [Abstract][Full Text] [Related]
19. Alterations in cadherin and catenin expression during the biological progression of melanocytic tumours.
Sanders DS; Blessing K; Hassan GA; Bruton R; Marsden JR; Jankowski J
Mol Pathol; 1999 Jun; 52(3):151-7. PubMed ID: 10621837
[TBL] [Abstract][Full Text] [Related]
20. Reduction of Membrane Protein CRIM1 Decreases E-Cadherin and Increases Claudin-1 and MMPs, Enhancing the Migration and Invasion of Renal Carcinoma Cells.
Ogasawara N; Kudo T; Sato M; Kawasaki Y; Yonezawa S; Takahashi S; Miyagi Y; Natori Y; Sugiyama A
Biol Pharm Bull; 2018; 41(4):604-611. PubMed ID: 29607933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]